4//SEC Filing
Duffield Jeremy 4
Accession 0001894562-25-000008
CIK 0001894562other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:15 PM ET
Size
5.4 KB
Accession
0001894562-25-000008
Insider Transaction Report
Form 4
Duffield Jeremy
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-27+275,000→ 275,000 totalExercise: $2.42Exp: 2035-02-27→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 27, 2025, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Prime Medicine, Inc.
CIK 0001894562
Entity typeother
Related Parties
1- filerCIK 0001922590
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:15 PM ET
- Size
- 5.4 KB